Literature DB >> 1390919

Thermodynamic analysis of heparin binding to human antithrombin.

S DeLauder1, F P Schwarz, J C Williams, D H Atha.   

Abstract

The binding of heparin to human antithrombin III (ATIII) was investigated by titration calorimetry (TC) and differential scanning calorimetry (DSC). TC measurements of homogeneous high-affinity pentasaccharide and octasaccharide fragments of heparin in 0.02 M phosphate buffer and 0.15 M sodium chloride (pH 7.3) yielded binding constants of (7.1 +/- 1.3) x 10(5) M-1 and (6.7 +/- 1.2) x 10(6) M-1, respectively, and corresponding binding enthalpies of -48.3 +/- 0.7 and -54.4 +/- 5.4 kJ mol-1. The binding enthalpy of heparin in phosphate buffer (0.02 M, 0.15 M NaCl, pH 7.3) was estimated from TC measurements to be -55 +/- 10 kJ mol-1, while the enthalpy in Tris buffer (0.02 M, 0.15 M NaCl, pH 7.3) was -18 +/- 2 kJ mol-1. The heparin-binding affinity was shown by fluorescence measurements not to change under these conditions. The 3-fold lower binding enthalpy in Tris can be attributed to the transfer of a proton from the buffer to the heparin-ATIII complex. DSC measurements of the ATIII unfolding transition exhibited a sharp denaturation peak at 329 +/- 1 K with a van 't Hoff enthalpy of 951 +/- 89 kJ mol-1, based on a two-state transition model and a much broader transition from 333 to 366 K. The transition peak at 329 K accounted for 9-18% of the total ATIII. At sub-saturate heparin concentrations, the lower temperature peak became bimodal with the appearance of a second transition peak at 336 K. At saturate heparin concentration only the 336 K peak was observed. This supports a two domain model of ATIII folding in which the lower stability domain (329 K) binds and is stabilized by heparin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1390919     DOI: 10.1016/0167-4838(92)90018-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  The N-terminal segment of antithrombin acts as a steric gate for the binding of heparin.

Authors:  H L Fitton; R Skinner; T R Dafforn; L Jin; R N Pike
Journal:  Protein Sci       Date:  1998-03       Impact factor: 6.725

2.  Thermodynamics of hydrogen cyanide and hydrogen fluoride binding to cytochrome c peroxidase and its Asn-82-->Asp mutant.

Authors:  S F DeLauder; J M Mauro; T L Poulos; J C Williams; F P Schwarz
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

3.  Mass Spectrometry Reveals a Multifaceted Role of Glycosaminoglycan Chains in Factor Xa Inactivation by Antithrombin.

Authors:  Burcu B Minsky; Rinat R Abzalimov; Chendi Niu; Yunlong Zhao; Zachary Kirsch; Paul L Dubin; Sergey N Savinov; Igor A Kaltashov
Journal:  Biochemistry       Date:  2018-07-25       Impact factor: 3.162

4.  Comparison of reversal activity and mechanism of action of UHRA, andexanet, and PER977 on heparin and oral FXa inhibitors.

Authors:  Manu T Kalathottukaren; A Louise Creagh; Srinivas Abbina; Genmin Lu; Mark J Karbarz; Anjali Pandey; Pamela B Conley; Jayachandran N Kizhakkedathu; Charles Haynes
Journal:  Blood Adv       Date:  2018-08-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.